Efficacy of standard dose and 30 ml/kg fresh frozen plasma in correcting laboratory parameters of haemostasis in critically ill patients.
about
Is solvent/detergent plasma better than standard fresh-frozen plasma? A systematic review and an expert consensus documentEarly and individualized goal-directed therapy for trauma-induced coagulopathyRole of prothrombin complex concentrate in perioperative coagulation therapyHaemostatic management of cardiac surgical haemorrhageThe European guideline on management of major bleeding and coagulopathy following trauma: fourth editionEffect of thromboelastography (TEG®) and rotational thromboelastometry (ROTEM®) on diagnosis of coagulopathy, transfusion guidance and mortality in trauma: descriptive systematic reviewPercutaneous interventions in the coagulopathic patient.Transfusion of fresh-frozen plasma in critically ill patients with a coagulopathy before invasive procedures: a randomized clinical trial (CME).Fibrinogen Early In Severe Trauma studY (FEISTY): study protocol for a randomised controlled trial.Recovery of fibrinogen after administration of fibrinogen concentrate to patients with severe bleeding after cardiopulmonary bypass surgery.Goal-directed coagulation management of major trauma patients using thromboelastometry (ROTEM)-guided administration of fibrinogen concentrate and prothrombin complex concentrateThe how's and why's of evidence based plasma therapy.Indications and organisational methods for autologous blood transfusion procedures in Italy: results of a national surveyBlood transfusion and the anaesthetist: management of massive haemorrhageSpanish Consensus Statement on alternatives to allogeneic blood transfusion: the 2013 update of the "Seville Document".Intraoperative transfusion practices in Europe.Recommendations for the transfusion management of patients in the peri-operative period. II. The intra-operative periodPlasma is ineffective in correcting mildly elevated PT-INR in critically ill children: a retrospective observational studyTrauma-induced coagulopathy: impact of the early coagulation support protocol on blood product consumption, mortality and costs.The conundrum of persistent inappropriate use of frozen plasma.Transfusion in trauma: thromboelastometry-guided coagulation factor concentrate-based therapy versus standard fresh frozen plasma-based therapy.A national study of plasma use in critical care: clinical indications, dose and effect on prothrombin time.Clinical review: Prothrombin complex concentrates--evaluation of safety and thrombogenicity.Clotting factor deficiency in early trauma-associated coagulopathy.Transfusion of fresh frozen plasma in non-bleeding ICU patients--TOPIC trial: study protocol for a randomized controlled trial.Clinical effectiveness of fresh frozen plasma compared with fibrinogen concentrate: a systematic review.Adverse effects of plasma transfusionReduction of Fresh Frozen Plasma Requirements by Perioperative Point-of-Care Coagulation Management with Early Calculated Goal-Directed Therapy.Prophylactic Fresh Frozen Plasma Infusion is Ineffective in Reversing Warfarin Anticoagulation and Preventing Delayed Intracranial Hemorrhage After Falls.Thromboelastometry-guided hemostatic therapy: an efficacious approach to manage bleeding risk in acute fatty liver of pregnancy: a case report.Transfusion practice in massively bleeding patients: time for a change?Tuscan study on the appropriateness of fresh-frozen plasma transfusion (TuSAPlaT).SDH with Bleeding Diathesis-a Management Protocol.Impact of experimental haemodilution on platelet function, thrombin generation and clot firmness: effects of different coagulation factor concentratesA multicenter study of plasma use in the United States.Importance of fibrinogen in dilutional coagulopathy after neurosurgical procedures: A descriptive studyEmergencies associated with pregnancy and delivery: peripartum hemorrhageBleeding management with fibrinogen concentrate targeting a high-normal plasma fibrinogen level: a pilot studyRecommendations for the transfusion of plasma and platelets.Reduction in plasma transfusion after enforcement of transfusion guidelines.
P2860
Q26748355-7E3DA552-1194-4253-9D78-E0F67FBF9034Q26853422-BA774DD1-0D33-4755-925D-47932F09D5DAQ26863536-73952CFB-1C12-4531-8148-F0DF2BCBAB19Q27024386-C7977355-3749-488F-8433-8ABA447B33C0Q27339343-B37D6E7C-409E-474B-9633-CCA71BD7CA0FQ30595449-F33E318B-7E8D-45F9-9599-4FCBCEECF29EQ33394177-947FE0EF-3806-4343-9273-22788FF9684AQ33415825-40B9F16E-54B3-4153-BDFD-A2C90C91E3D6Q33733852-50F8717C-A99B-42B8-A8AD-3DDF6F845C4FQ33793633-8FB6DBAE-6C22-4645-AFF9-AA987AA96CDDQ33919203-61CE2538-BA7E-4B51-868A-6849C48D0396Q34316974-D06E7791-E1E3-4E6F-BF0B-60663F3BBE30Q34416339-97B8B90D-23B0-419C-A6F1-A118637AB72CQ34548386-7912F81B-88CA-4B46-8591-A95C8D0C4166Q34654443-27686176-2D3F-4601-AAAF-A4243536E6C2Q34675297-F501EEB6-59E0-4BB0-9150-3EF3FBA644A6Q34988663-B109020A-0C9F-4A68-B483-B8182074AE10Q35106675-DEAC29DC-58E8-4AE4-B612-6864E5F5EE2BQ35248569-B7A8808C-E0A9-4DA9-A0C9-AC46AB3A1DFBQ35558167-C9B16F10-5CBB-452B-B73B-7C98056D7751Q35559379-DC85F234-966B-456C-9D54-4D5CEFDD3C3BQ35559573-99D8AEF6-A198-44CB-9D9B-F3626B8F9AC5Q35567088-D0551536-D109-44E2-93F9-7F09D6E6DDAEQ35621790-949FC562-51E0-4C62-B6D3-CBF57E37BCC3Q35772078-4B62F904-91E4-475F-BCA9-A47073DB5300Q35908250-74CF318D-0FCB-4AF2-8DF8-52E5C6489450Q35972184-4F890903-A023-4251-9612-9A419E94C1A4Q35998384-5461EDD5-C35D-4FAD-A85E-CBE9D47B9B1BQ36066343-7D7F3CF6-61DD-4000-BA33-F6DD089F9117Q36086090-B9AF06B0-91DA-4768-9A12-F8B3D3178E62Q36230698-B41092F3-318D-48ED-97B5-6781A9485874Q36874231-925739C8-1F77-4F7A-B0E7-09A7EB094884Q36923936-77C5B4C4-0EB0-4CD8-8593-F9FD939BE4EFQ37059222-B243F18B-A31F-4D24-8C60-692D7FDC5B6BQ37141692-1677F12E-A308-4C74-9A3B-62B9B3ABFE5AQ37186526-AA63D58C-2E9F-47A9-85BA-D3A5BFD07C5FQ37188102-576F515F-3501-4D10-AFDE-61C004666B16Q37195366-343D96C5-F245-4D96-8575-F75BC90D6576Q37209117-F60F1F53-5BA5-4712-8E1B-112DDAAA09F0Q37800127-2B20EB43-EE18-4B23-95CF-5692CCCCA229
P2860
Efficacy of standard dose and 30 ml/kg fresh frozen plasma in correcting laboratory parameters of haemostasis in critically ill patients.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Efficacy of standard dose and ...... is in critically ill patients.
@ast
Efficacy of standard dose and ...... is in critically ill patients.
@en
type
label
Efficacy of standard dose and ...... is in critically ill patients.
@ast
Efficacy of standard dose and ...... is in critically ill patients.
@en
prefLabel
Efficacy of standard dose and ...... is in critically ill patients.
@ast
Efficacy of standard dose and ...... is in critically ill patients.
@en
P2093
P2860
P1476
Efficacy of standard dose and ...... sis in critically ill patients
@en
P2093
Anton G Saayman
George P Findlay
Peter W Collins
Ulrike Paulus
P2860
P356
10.1111/J.1365-2141.2004.04868.X
P407
P577
2004-04-01T00:00:00Z